<address id="xnfdl"><listing id="xnfdl"><menuitem id="xnfdl"></menuitem></listing></address>

<address id="xnfdl"></address>
<address id="xnfdl"><nobr id="xnfdl"><meter id="xnfdl"></meter></nobr></address>
<address id="xnfdl"><listing id="xnfdl"><meter id="xnfdl"></meter></listing></address>

<address id="xnfdl"></address>
WAP手機版 RSS訂閱 加入收藏  設為首頁
當前位置:首頁 > 外語考試


時間:2017/5/6 14:03:14   作者:admin   來源:中國考試網   閱讀:147   評論:0
內容摘要: Changes in Air  A  A federal ban on ozone-depleting chlorofluorocarbons (CFCs), to conform with the Clean Air Act, is, ironically, affectin...

 Changes in Air


  A federal ban on ozone-depleting chlorofluorocarbons (CFCs), to conform with the Clean Air Act, is, ironically, affecting 22.9 million people in the U.S. who suffer from asthma, Genetic inhaled albuterol, which is the most commonly prescribed short-acting asthma medication and requires CFCs to propel it into the lungs, will no longer be legally sold after December 31, 2008. Physicians and patients are questioning the wisdom of the ban, which will have an insignificant effect on ozone but a measurable impact on wallets: the reformulated brand-name alternatives can be three times as expensive, raising the cost to about $40 per inhaler. The issue is even more disconcerting considering that asthma disproportionately affects the poor and that according to recent surveys, an estimated 20 percent of asthma patients are uninsured.


  "The decision to make the change was political, not medical or scientific," says pharmacist Leslie Hendeles of the University of Florida, who co-authored a 2007 paper in the New England Journal of Medicine explaining the withdrawal and transition. In 1987 Congress signed on to the Montreal Protocol on Substances That Deplete the Ozone Layer, an international treaty requiring the phasing out of all nonessential uses of CFCs. At that time, medical inhalers were considered an essential use because no viable alternative propellant existed. In 1989 pharmaceutical companies banded together and eventually, in 1996, reformulated albuterol with hydrofluoroalkane.


  The transition began quietly, but as more patients see their prescriptions change and costs go up, many question why this bail must begin before generics become available. At least one member of the FDA advisory committee, Nicholas J. Gross of the Stritch-Loyola School of Medicine, has publicly regretted the decision, recanting his support and requesting that the ban be pushed back until 2010, when the first patent expires.


  Gross notes that the decision had nothing to do with the environment Albuterol inhalers contributed less than 0.1 percent of the CFCs released when the treaty was signed. "Lt's a symbolic issue" Gross remarks. Some skeptics instead point to the billions of dollars to be gained by the three companies holding the patents on the available HFA-albuterol inhalers, namely Glaxo-SmithKline, Schering-Plough and Teva. Although the FDA advisory committee recognized that the expenses would go up, Hendeles says, it also believed that the companies would help defray the added costs for individuals, Firms, for instance, had committed to donating a million HFA inhalers to clinics around the country. According to Hendeles, GlaxoSmithKline did not follow through, although Schering-Plough and Teva did. GlaxoSmithKline did not respond to requests for comment.


  The issue now, Hendeles says, is that pharmaceutical-grade CFCs are in short supply, and the public faces the risk of a shortage of albuterol inhalers if the FDA does not continue promoting the production of HFA inhalers. He posits that even costs of generics would go up as CFCs become scarcer. Gross disagrees, saying that the inhaler shortage and the closure of CFC manufacturing plants are a result of the ban.


  The HFA inhalers also have encountered resistance because some asthmatics insist that they do not work as well as the CFC variety. But, Hendeles says, the differences are in the mechanics and maintenance—unlike CFC inhalers, the HFA versions must be primed more diligently and rinsed to accommodate the stickier HFA formulation. They also run out suddenly without the warning with a CFC inhaler, that the device is running low. "Pharmacists may not tell people of these things, and the doctors don't know," Hendeles says.


  The main public health issue in this decision may be the side effects of the economics, not the drug chemistry. Multiple studies have shown that raising costs leads to poorer adherence to treatment. One study discovered that patients took 30 percent less amtiasthma medication when their co-pay doubled. In the ease of a chronic disease such as asthma, it is particularly difficult to get people to follow regular treatment plans. "Generally speaking, for any reason you don’t take medication, cost makes it more likely” that you do not, comments Michael Chernew, a health policy expert at Harvard Medical School.


  Such choices to forgo medication could affect more than just the patients themselves. "For example," Hendeles points out, "in a pregnant mother with untreated asthma, less oxygen is delivered to the fetus, which can lead to congenital problems and premature birth." And considering that the disease disproportionately strikes the poor, what seemed to be a good, responsible environmental decision might in the end exact an unexpected human toll.

  Question 14-18

  Use the information in the passage to match the people (listed A-C) with opinions or deeds below. Write the appropriate letters A-C in boxes 14-18 on your answer sheet.

  NB you may use any letter more than once

  A Nicholas J. Gross

  B Michael Chernew

  C Leslie Hendeles

  14. Put forward that the increase in the price of drugs would contribute to the patients' negative decision on the treatment.

  15. Spoke out a secret that the druggists try to hold back.

  16. Pointed out that the protocol itself is not concerning the environment.

  17. Demonstrated that the stop of providing alternatives for CFCs would worsen rather than help with the situation.

  18. In public repented of his previous backing up of the prohibition proposal.

  Question 19-22

  Do the following statements agree with the information given in Reading Passage?

  In boxes 19-22 on your answer sheet, write

  TRUE if the statement is true

  FALSE if the statement is false

  NOT GIVEN if the information is not given in the passage

  19. It took almost a decade before the replacement drug for the asthma therapy was ultimately developed by the joint effort of several drug companies.

  20. One of the FDA committee members had a decisive impact on the implement of the ban on chlorofluorocarbons.

  21. As a matter of fact, the emitted chlorofluorocarbons in asthma treatment took up quite an insignificant amount at the time when the pact was reached.

  22. The HFA and CFC inhalers have something different regarding the therapeutic effect.

  Question 23-27

  Complete the following summary of the paragraphs of Reading Passage, using No More than Three words from the Reading Passage for each answer. Write your answers in boxes 23-27 on your answer sheet.

  American people with asthma would be impacted by...23...about chlorofluorocarbons which would consume the ozone layer. The usually used...24...would be considered illegal because it needs the propelment of...25.... The...26...would cost the patients considerably more money. Impoverished people are far more likely to Suffer from asthma and what makes it even worse is that some of them are in...27...condition.

Copyright ©2017 www.cseurope.net
梦想彩票 广汉 衡阳 葫芦岛 泰州 石狮 灵宝 昌都 萍乡 垦利 巢湖 张北 滁州 乳山 崇左 宝应县 海宁 通辽 宜昌 淮安 瓦房店 信阳 芜湖 大兴安岭 漯河 安阳 公主岭 怒江 伊春 德阳 吉林 和田 九江 菏泽 厦门 日照 黔南 博尔塔拉 儋州 玉林 泗阳 灵宝 文山 三沙 中卫 大连 绵阳 灵宝 福建福州 天长 莆田 宿迁 遂宁 承德 台州 乌兰察布 泗洪 菏泽 定西 瑞安 秦皇岛 佛山 儋州 桐乡 揭阳 江苏苏州 临汾 仙桃 库尔勒 荣成 新乡 娄底 梧州 嘉兴 肥城 平潭 德清 张北 玉林 昌吉 运城 云浮 白山 邯郸 桐城 唐山 宿迁 南安 松原 宝鸡 庆阳 梅州 湛江 兴安盟 兴安盟 北海 资阳 玉林 三河 包头 曹县 海拉尔 日照 沧州 宜都 内江 上饶 常州 定州 单县 南通 晋城 瓦房店 余姚 灵宝 鹤壁 保定 安庆 伊犁 德州 洛阳 海南海口 保定 景德镇 石狮 周口 三门峡 哈密 鄂州 垦利 沧州 贵港 那曲 三亚 宿迁 淄博 塔城 宁夏银川 红河 普洱 莆田 保定 汕尾 福建福州 连云港 公主岭 惠东 泰安 桂林 广汉 泗洪 大丰 高密 辽阳 吐鲁番 广州 乐平 常州 三亚 遵义 无锡 宣城 南京 鄂州 玉树 乳山 黔东南 湘西 诸暨 新余 抚顺 焦作 玉环 永康 黔西南 日照 贵州贵阳 郴州 齐齐哈尔 白山 日喀则 日喀则 鹤岗 南阳 河池 日喀则 枣庄 岳阳 宜都 石河子 公主岭 德清 固原 滨州 长兴 松原 鹰潭 广汉 淄博 巴音郭楞 三门峡 长垣 遂宁 铜川 海丰 甘孜 锦州 建湖 天水 义乌 榆林 许昌 文昌 垦利 青海西宁 正定 甘肃兰州 商丘 固原 浙江杭州 单县 大连 西双版纳 阿拉尔 滨州 安徽合肥 象山 济宁 文山 苍南 河池 阿里 常德 张家口 鸡西 泸州 东海 文山 三门峡 佛山 海丰 达州 乳山 黑河 阜阳 和田 云浮 辽源 汝州 昌都 邹平 安吉 长兴 衡阳 宜昌 惠州 万宁 青海西宁 儋州 靖江 阜阳